Structure

Physi-Chem Properties

Molecular Weight:  504.16
Volume:  488.251
LogP:  1.742
LogD:  1.53
LogS:  -3.617
# Rotatable Bonds:  10
TPSA:  161.21
# H-Bond Aceptor:  11
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.219
Synthetic Accessibility Score:  3.735
Fsp3:  0.36
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.921
MDCK Permeability:  4.164017445873469e-05
Pgp-inhibitor:  0.193
Pgp-substrate:  0.347
Human Intestinal Absorption (HIA):  0.82
20% Bioavailability (F20%):  0.097
30% Bioavailability (F30%):  0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.384
Plasma Protein Binding (PPB):  96.18038177490234%
Volume Distribution (VD):  0.417
Pgp-substrate:  6.068342685699463%

ADMET: Metabolism

CYP1A2-inhibitor:  0.148
CYP1A2-substrate:  0.628
CYP2C19-inhibitor:  0.2
CYP2C19-substrate:  0.341
CYP2C9-inhibitor:  0.482
CYP2C9-substrate:  0.81
CYP2D6-inhibitor:  0.129
CYP2D6-substrate:  0.641
CYP3A4-inhibitor:  0.202
CYP3A4-substrate:  0.205

ADMET: Excretion

Clearance (CL):  6.96
Half-life (T1/2):  0.925

ADMET: Toxicity

hERG Blockers:  0.293
Human Hepatotoxicity (H-HT):  0.133
Drug-inuced Liver Injury (DILI):  0.21
AMES Toxicity:  0.246
Rat Oral Acute Toxicity:  0.037
Maximum Recommended Daily Dose:  0.027
Skin Sensitization:  0.8
Carcinogencity:  0.286
Eye Corrosion:  0.003
Eye Irritation:  0.025
Respiratory Toxicity:  0.043

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471405

Natural Product ID:  NPC471405
Common Name*:   Scroneoside A
IUPAC Name:   [(2R,3S,4S,5R,6S)-6-(4-acetyl-2-methoxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  MHPWKMWQIOIJHD-WDOAYHAPSA-N
Standard InCHI:  InChI=1S/C25H28O11/c1-13(26)15-6-8-17(19(11-15)33-3)35-25-24(31)23(30)22(29)20(36-25)12-34-21(28)9-5-14-4-7-16(27)18(10-14)32-2/h4-11,20,22-25,27,29-31H,12H2,1-3H3/b9-5+/t20-,22-,23+,24-,25-/m1/s1
SMILES:  COc1cc(ccc1O[C@@H]1O[C@H](COC(=O)/C=C/c2ccc(c(c2)OC)O)[C@H]([C@@H]([C@H]1O)O)O)C(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2436435
PubChem CID:   73347939
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30241 Picrorhiza scrophulariiflora Species Plantaginaceae Eukaryota n.a. root n.a. PMID[15133218]
NPO30241 Picrorhiza scrophulariiflora Species Plantaginaceae Eukaryota n.a. root n.a. PMID[15706916]
NPO30241 Picrorhiza scrophulariiflora Species Plantaginaceae Eukaryota n.a. n.a. n.a. PMID[24035096]
NPO30241 Picrorhiza scrophulariiflora Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO30241 Picrorhiza scrophulariiflora Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 > 25000.0 nM PMID[529909]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471405 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9932 High Similarity NPC10205
0.9865 High Similarity NPC191046
0.9865 High Similarity NPC194095
0.9865 High Similarity NPC327032
0.9797 High Similarity NPC157898
0.9797 High Similarity NPC137813
0.973 High Similarity NPC134905
0.973 High Similarity NPC36130
0.9671 High Similarity NPC203020
0.9671 High Similarity NPC239966
0.9669 High Similarity NPC133984
0.9605 High Similarity NPC160780
0.9605 High Similarity NPC289811
0.9595 High Similarity NPC205054
0.9539 High Similarity NPC226759
0.9539 High Similarity NPC472860
0.9539 High Similarity NPC1913
0.9527 High Similarity NPC111785
0.9527 High Similarity NPC98809
0.9527 High Similarity NPC476394
0.9481 High Similarity NPC311803
0.9481 High Similarity NPC472859
0.9481 High Similarity NPC25389
0.9459 High Similarity NPC472969
0.9427 High Similarity NPC116745
0.9419 High Similarity NPC285108
0.9419 High Similarity NPC33298
0.9416 High Similarity NPC166277
0.9416 High Similarity NPC119125
0.9351 High Similarity NPC74319
0.9351 High Similarity NPC287872
0.9324 High Similarity NPC291153
0.9295 High Similarity NPC148273
0.929 High Similarity NPC289346
0.9276 High Similarity NPC310661
0.9276 High Similarity NPC105827
0.9267 High Similarity NPC478242
0.9236 High Similarity NPC88043
0.9211 High Similarity NPC75695
0.9193 High Similarity NPC88560
0.9193 High Similarity NPC175230
0.9193 High Similarity NPC172033
0.9189 High Similarity NPC473090
0.9187 High Similarity NPC204937
0.9187 High Similarity NPC149011
0.9177 High Similarity NPC165720
0.9172 High Similarity NPC90905
0.9172 High Similarity NPC4013
0.915 High Similarity NPC44730
0.9145 High Similarity NPC140151
0.913 High Similarity NPC172807
0.913 High Similarity NPC211594
0.913 High Similarity NPC254540
0.9125 High Similarity NPC658
0.9125 High Similarity NPC229687
0.9125 High Similarity NPC197708
0.9122 High Similarity NPC478239
0.9085 High Similarity NPC289438
0.9079 High Similarity NPC473091
0.9074 High Similarity NPC4390
0.9074 High Similarity NPC316539
0.9074 High Similarity NPC472993
0.9068 High Similarity NPC212748
0.9067 High Similarity NPC287495
0.9067 High Similarity NPC9370
0.9062 High Similarity NPC229729
0.9062 High Similarity NPC45400
0.9062 High Similarity NPC298847
0.9057 High Similarity NPC180586
0.9057 High Similarity NPC22832
0.9057 High Similarity NPC311830
0.9054 High Similarity NPC140502
0.9054 High Similarity NPC157816
0.9051 High Similarity NPC41009
0.9051 High Similarity NPC127782
0.9051 High Similarity NPC300537
0.9045 High Similarity NPC44507
0.9038 High Similarity NPC40920
0.9038 High Similarity NPC223335
0.9026 High Similarity NPC245615
0.9026 High Similarity NPC61604
0.9026 High Similarity NPC299706
0.9026 High Similarity NPC115466
0.9024 High Similarity NPC267549
0.9018 High Similarity NPC477848
0.9013 High Similarity NPC92117
0.9012 High Similarity NPC472386
0.9012 High Similarity NPC307518
0.9012 High Similarity NPC190003
0.9012 High Similarity NPC102851
0.9012 High Similarity NPC153755
0.9012 High Similarity NPC175107
0.9012 High Similarity NPC48773
0.9012 High Similarity NPC5786
0.9012 High Similarity NPC205076
0.9006 High Similarity NPC105025
0.9006 High Similarity NPC475942
0.9006 High Similarity NPC469931
0.9006 High Similarity NPC45638
0.9006 High Similarity NPC58053
0.9006 High Similarity NPC93337
0.9006 High Similarity NPC226294
0.9006 High Similarity NPC186807
0.9006 High Similarity NPC201292
0.9 High Similarity NPC236934
0.9 High Similarity NPC5778
0.8994 High Similarity NPC147596
0.8994 High Similarity NPC243930
0.8994 High Similarity NPC222936
0.8994 High Similarity NPC191306
0.8994 High Similarity NPC284960
0.8994 High Similarity NPC19709
0.8994 High Similarity NPC168822
0.8994 High Similarity NPC88023
0.8994 High Similarity NPC270335
0.8994 High Similarity NPC309025
0.8986 High Similarity NPC186406
0.8986 High Similarity NPC326065
0.8981 High Similarity NPC469654
0.8968 High Similarity NPC469888
0.8963 High Similarity NPC472991
0.8963 High Similarity NPC472992
0.8963 High Similarity NPC233994
0.8963 High Similarity NPC67629
0.8963 High Similarity NPC79736
0.8963 High Similarity NPC472385
0.8963 High Similarity NPC211532
0.8963 High Similarity NPC198324
0.8957 High Similarity NPC163165
0.8954 High Similarity NPC227980
0.8954 High Similarity NPC182350
0.8951 High Similarity NPC72249
0.8951 High Similarity NPC155763
0.8951 High Similarity NPC105511
0.8951 High Similarity NPC51326
0.8951 High Similarity NPC21190
0.8951 High Similarity NPC224462
0.8951 High Similarity NPC183357
0.8951 High Similarity NPC22195
0.8951 High Similarity NPC235260
0.8951 High Similarity NPC34287
0.8951 High Similarity NPC206123
0.8951 High Similarity NPC244776
0.8951 High Similarity NPC474434
0.8951 High Similarity NPC116864
0.8951 High Similarity NPC471416
0.8951 High Similarity NPC20505
0.8951 High Similarity NPC231194
0.8951 High Similarity NPC44558
0.8947 High Similarity NPC248257
0.8947 High Similarity NPC120621
0.8947 High Similarity NPC116229
0.8944 High Similarity NPC45618
0.8944 High Similarity NPC146792
0.8944 High Similarity NPC58716
0.894 High Similarity NPC199928
0.894 High Similarity NPC473867
0.8938 High Similarity NPC475738
0.8933 High Similarity NPC232228
0.8931 High Similarity NPC77660
0.8931 High Similarity NPC61594
0.8931 High Similarity NPC189142
0.8931 High Similarity NPC473043
0.8931 High Similarity NPC476011
0.8931 High Similarity NPC22324
0.8931 High Similarity NPC56735
0.8924 High Similarity NPC53889
0.891 High Similarity NPC131532
0.8909 High Similarity NPC472387
0.8909 High Similarity NPC476620
0.8909 High Similarity NPC476623
0.8909 High Similarity NPC476622
0.8909 High Similarity NPC217520
0.8909 High Similarity NPC35167
0.8909 High Similarity NPC476621
0.8909 High Similarity NPC476618
0.8909 High Similarity NPC476619
0.8909 High Similarity NPC139571
0.8902 High Similarity NPC210094
0.8902 High Similarity NPC43211
0.8902 High Similarity NPC49344
0.8902 High Similarity NPC169645
0.8902 High Similarity NPC84482
0.8902 High Similarity NPC237435
0.8902 High Similarity NPC115760
0.8902 High Similarity NPC135277
0.8902 High Similarity NPC264735
0.8902 High Similarity NPC101191
0.8896 High Similarity NPC243891
0.8896 High Similarity NPC476405
0.8896 High Similarity NPC47140
0.8896 High Similarity NPC67134
0.8896 High Similarity NPC235575
0.8896 High Similarity NPC117260
0.8889 High Similarity NPC95421
0.8889 High Similarity NPC170675
0.8889 High Similarity NPC203050
0.8889 High Similarity NPC209296
0.8889 High Similarity NPC471457
0.8889 High Similarity NPC95855

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471405 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8944 High Similarity NPD3818 Discontinued
0.8902 High Similarity NPD4338 Clinical (unspecified phase)
0.8889 High Similarity NPD7054 Approved
0.8834 High Similarity NPD7472 Approved
0.8834 High Similarity NPD7074 Phase 3
0.8734 High Similarity NPD4868 Clinical (unspecified phase)
0.8727 High Similarity NPD7685 Pre-registration
0.8667 High Similarity NPD6797 Phase 2
0.8614 High Similarity NPD7251 Discontinued
0.8563 High Similarity NPD7808 Phase 3
0.8562 High Similarity NPD4381 Clinical (unspecified phase)
0.8544 High Similarity NPD1934 Approved
0.8477 Intermediate Similarity NPD7266 Discontinued
0.8387 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD2801 Approved
0.8375 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD6166 Phase 2
0.8364 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD3817 Phase 2
0.8312 Intermediate Similarity NPD4628 Phase 3
0.8291 Intermediate Similarity NPD1653 Approved
0.8272 Intermediate Similarity NPD3882 Suspended
0.8258 Intermediate Similarity NPD6190 Approved
0.8198 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD6559 Discontinued
0.8148 Intermediate Similarity NPD1465 Phase 2
0.811 Intermediate Similarity NPD7075 Discontinued
0.8107 Intermediate Similarity NPD5844 Phase 1
0.8107 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD6234 Discontinued
0.8047 Intermediate Similarity NPD7228 Approved
0.8038 Intermediate Similarity NPD1511 Approved
0.8026 Intermediate Similarity NPD230 Phase 1
0.7977 Intermediate Similarity NPD8313 Approved
0.7977 Intermediate Similarity NPD8312 Approved
0.7975 Intermediate Similarity NPD37 Approved
0.7964 Intermediate Similarity NPD7199 Phase 2
0.7963 Intermediate Similarity NPD4380 Phase 2
0.7955 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD4965 Approved
0.7939 Intermediate Similarity NPD4966 Approved
0.7939 Intermediate Similarity NPD4967 Phase 2
0.7937 Intermediate Similarity NPD1512 Approved
0.7927 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD5402 Approved
0.7867 Intermediate Similarity NPD9494 Approved
0.7866 Intermediate Similarity NPD6801 Discontinued
0.7865 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD8455 Phase 2
0.7818 Intermediate Similarity NPD7819 Suspended
0.7812 Intermediate Similarity NPD6799 Approved
0.7811 Intermediate Similarity NPD6232 Discontinued
0.7798 Intermediate Similarity NPD5494 Approved
0.7792 Intermediate Similarity NPD1933 Approved
0.7778 Intermediate Similarity NPD7473 Discontinued
0.7765 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD1549 Phase 2
0.7718 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD6386 Approved
0.7697 Intermediate Similarity NPD7411 Suspended
0.7697 Intermediate Similarity NPD6385 Approved
0.7677 Intermediate Similarity NPD447 Suspended
0.7669 Intermediate Similarity NPD5403 Approved
0.7658 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD3027 Phase 3
0.763 Intermediate Similarity NPD3751 Discontinued
0.7613 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD1613 Approved
0.7576 Intermediate Similarity NPD7458 Discontinued
0.7557 Intermediate Similarity NPD7038 Approved
0.7557 Intermediate Similarity NPD7240 Approved
0.7557 Intermediate Similarity NPD7039 Approved
0.7548 Intermediate Similarity NPD6233 Phase 2
0.7546 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD5401 Approved
0.753 Intermediate Similarity NPD6599 Discontinued
0.7516 Intermediate Similarity NPD3750 Approved
0.7516 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3787 Discontinued
0.7484 Intermediate Similarity NPD2796 Approved
0.7484 Intermediate Similarity NPD2935 Discontinued
0.7484 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD3226 Approved
0.7456 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD5353 Approved
0.7447 Intermediate Similarity NPD7435 Discontinued
0.7444 Intermediate Similarity NPD8434 Phase 2
0.7442 Intermediate Similarity NPD8127 Discontinued
0.7439 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD9545 Approved
0.7421 Intermediate Similarity NPD1510 Phase 2
0.7417 Intermediate Similarity NPD1608 Approved
0.7414 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.738 Intermediate Similarity NPD6779 Approved
0.738 Intermediate Similarity NPD6780 Approved
0.738 Intermediate Similarity NPD6781 Approved
0.738 Intermediate Similarity NPD6782 Approved
0.738 Intermediate Similarity NPD6778 Approved
0.738 Intermediate Similarity NPD6777 Approved
0.738 Intermediate Similarity NPD6776 Approved
0.7372 Intermediate Similarity NPD6798 Discontinued
0.7365 Intermediate Similarity NPD3455 Phase 2
0.7356 Intermediate Similarity NPD5242 Approved
0.7355 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD1091 Approved
0.7346 Intermediate Similarity NPD6674 Discontinued
0.7344 Intermediate Similarity NPD8151 Discontinued
0.7341 Intermediate Similarity NPD6959 Discontinued
0.7333 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD2346 Discontinued
0.7326 Intermediate Similarity NPD919 Approved
0.7312 Intermediate Similarity NPD2799 Discontinued
0.7312 Intermediate Similarity NPD7033 Discontinued
0.7303 Intermediate Similarity NPD9269 Phase 2
0.7301 Intermediate Similarity NPD4110 Phase 3
0.7301 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD6273 Approved
0.7284 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD943 Approved
0.7278 Intermediate Similarity NPD1240 Approved
0.7268 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7783 Phase 2
0.7267 Intermediate Similarity NPD1551 Phase 2
0.7267 Intermediate Similarity NPD3749 Approved
0.7262 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD2313 Discontinued
0.7261 Intermediate Similarity NPD3764 Approved
0.7257 Intermediate Similarity NPD3926 Phase 2
0.7256 Intermediate Similarity NPD2354 Approved
0.7256 Intermediate Similarity NPD3887 Approved
0.725 Intermediate Similarity NPD7097 Phase 1
0.7248 Intermediate Similarity NPD5536 Phase 2
0.7244 Intermediate Similarity NPD6832 Phase 2
0.7234 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD6355 Discontinued
0.7219 Intermediate Similarity NPD17 Approved
0.7216 Intermediate Similarity NPD7874 Approved
0.7216 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD4062 Phase 3
0.7209 Intermediate Similarity NPD7768 Phase 2
0.7205 Intermediate Similarity NPD3748 Approved
0.7202 Intermediate Similarity NPD7585 Approved
0.7195 Intermediate Similarity NPD8166 Discontinued
0.7188 Intermediate Similarity NPD1607 Approved
0.7173 Intermediate Similarity NPD7698 Approved
0.7173 Intermediate Similarity NPD7697 Approved
0.7173 Intermediate Similarity NPD7680 Approved
0.7173 Intermediate Similarity NPD7696 Phase 3
0.7161 Intermediate Similarity NPD1203 Approved
0.7158 Intermediate Similarity NPD8150 Discontinued
0.7152 Intermediate Similarity NPD3268 Approved
0.715 Intermediate Similarity NPD7583 Approved
0.715 Intermediate Similarity NPD7584 Approved
0.7143 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1247 Approved
0.7135 Intermediate Similarity NPD7871 Phase 2
0.7135 Intermediate Similarity NPD7870 Phase 2
0.7129 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD2532 Approved
0.7126 Intermediate Similarity NPD2534 Approved
0.7126 Intermediate Similarity NPD2533 Approved
0.7126 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD3146 Approved
0.7125 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD3705 Approved
0.712 Intermediate Similarity NPD6823 Phase 2
0.7117 Intermediate Similarity NPD2344 Approved
0.7113 Intermediate Similarity NPD7701 Phase 2
0.7112 Intermediate Similarity NPD6534 Approved
0.7112 Intermediate Similarity NPD6535 Approved
0.7111 Intermediate Similarity NPD5953 Discontinued
0.7108 Intermediate Similarity NPD7440 Discontinued
0.7099 Intermediate Similarity NPD4308 Phase 3
0.7091 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD7095 Approved
0.7081 Intermediate Similarity NPD6653 Approved
0.7078 Intermediate Similarity NPD1481 Phase 2
0.7063 Intermediate Similarity NPD4060 Phase 1
0.7051 Intermediate Similarity NPD2797 Approved
0.7047 Intermediate Similarity NPD8319 Approved
0.7047 Intermediate Similarity NPD8320 Phase 1
0.7041 Intermediate Similarity NPD920 Approved
0.7039 Intermediate Similarity NPD1357 Approved
0.7039 Intermediate Similarity NPD9268 Approved
0.7039 Intermediate Similarity NPD2163 Approved
0.7035 Intermediate Similarity NPD6844 Discontinued
0.703 Intermediate Similarity NPD1652 Phase 2
0.7019 Intermediate Similarity NPD4340 Discontinued
0.7018 Intermediate Similarity NPD7028 Phase 2
0.7016 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD1535 Discovery
0.7013 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD2353 Approved
0.7012 Intermediate Similarity NPD2343 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data